Search Results - Anthony Conley
- Showing 1 - 5 results of 5
-
1
-
2
-
3
1523 AdAPT-001 in advanced soft-tissue sarcoma (BETA PRIME): a multicenter, open-label, phase 1 clinical trial by Anthony Conley, Tony Reid, Santosh Kesari, Jeannie Williams, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Erica Burbano, Nacer Abrouk
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
4
Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma by Hannah C. Beird, Chia-Chin Wu, Michael Nakazawa, Davis Ingram, Joseph R. Daniele, Rossana Lazcano, Latasha Little, Christopher Davies, Najat C. Daw, Khalida Wani, Wei-Lien Wang, Xingzhi Song, Curtis Gumbs, Jianhua Zhang, Brian Rubin, Anthony Conley, Adrienne M. Flanagan, Alexander J. Lazar, P. Andrew Futreal
Published in HGG Advances (2023-10-01)Get full text
Article -
5
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience by Madeline B. Torres, Madeline B. Torres, Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis Ingram, Khalida Wani, Emily Z. Keung, M. Alejandra Zarzour, Christopher P. Scally, Kelly K. Hunt, Anthony Conley, Andrew J. Bishop, B. Ashleigh Guadagnolo, Ahsan Farooqi, Devarati Mitra, Alison K. Yoder, Michael S. Nakazawa, Dejka Araujo, Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Alexander J. Lazar, Alexander J. Lazar, Christina L. Roland, Neeta Somaiah, Elise F. Nassif Haddad, Elise F. Nassif Haddad
Published in Frontiers in Immunology (2025-04-01)Get full text
Article
